CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 72 enrolled
Drug / intervention
Diclofenac diethylamine 1.16% gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01335724
NCT01335724Phase 4Completed
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled, Multi-center Parallel Group Phase IV Study to Evaluate the Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

Novartis·interventional·Posted Apr 14, 2011·Updated Jul 18, 2012

In Brief

A Phase 4 clinical trial evaluating Diclofenac diethylamine 1.16% gel and Placebo gel for Neck Pain. Completed, enrolled 72 participants across 3 sites.

Detailed Summary

The purpose of this study is to evaluate the efficacy and safety of diclofenac 1.16% gel compared with placebo applied four times a day in subjects with acute neck pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeck Pain
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 14, 2011
Enrollment StartApr 1, 2011
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.2 years ago

Interventions

Diclofenac diethylamine 1.16% geldrug

Diclofenac diethylamine 1.16% gel

Placebo geldrug

Placebo gel